Defining super-enhancer landscape in triple-negative breast cancer by multiomic profiling

$ 13.99

5
(307)
In stock
Description

IJMS, Free Full-Text

Single-Cell Transcriptional and Epigenetic Profiles of Male Breast Cancer Nominate Salient Cancer-Specific Enhancers

Etiology of super-enhancer reprogramming and activation in cancer, Epigenetics & Chromatin

CityU biologists discover super-enhancers that switch on breast cancer genes

Frontiers Super enhancer-driven core transcriptional regulatory circuitry crosstalk with cancer plasticity and patient mortality in triple-negative breast cancer

EphA2 super-enhancer promotes tumor progression by recruiting FOSL2 and TCF7L2 to activate the target gene EphA2

Cancers, Free Full-Text

Super-enhancer profiling identifies novel critical and targetable cancer survival gene LYL1 in pediatric acute myeloid leukemia, Journal of Experimental & Clinical Cancer Research

RNA-Seq assay identifies target genes of MLL3 and MLL4 in metabolism.

Super-enhancers complexes zoom in transcription in cancer, Journal of Experimental & Clinical Cancer Research

TCOF1 upregulation in triple-negative breast cancer promotes stemness and tumour growth and correlates with poor prognosis

Deciphering the gene regulatory circuitry governing chemoresistance in Triple-Negative Breast Cancer

Cancers, Free Full-Text

Oncogenic super-enhancers in cancer: mechanisms and therapeutic targets